LFG
MIRM icon

Larson Financial Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Larson Financial Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Sell
129
-12
-9% -$1.21K ﹤0.01% 2169
2026
Q1 		$13K Buy
141
+6
+4% +$564 ﹤0.01% 2090
2025
Q4 		$10.7K Buy
135
+5
+4% +$359 ﹤0.01% 2086
2025
Q3 		$9.53K Buy
130
+127
+4,233% +$8.07K ﹤0.01% 2040
2025
Q2 		$153 Buy
+3
New +$134 ﹤0.01% 3107

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Larson Financial Group's MIRM Position: Q2 2026 in Review

Larson Financial Group reduced its Mirum Pharmaceuticals (MIRM) stake by 8.5% in Q2 2026, selling an estimated $1.21K and leaving 129 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2169.

Larson Financial Group first reported a position in MIRM in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Larson Financial Group held 129 shares of Mirum Pharmaceuticals worth $15.1K as of Q2 2026.
  • Larson Financial Group sold 12 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.21K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2169 holding.
  • Larson Financial Group first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.